Class II — AbbVie Inc.
| Recalling firm | AbbVie Inc. |
|---|---|
| Registered facility | View this company's 5 registered facilities → (openFDA recall records do not name a specific facility) |
| Classification | Class II |
| Status | Terminated |
| Reason | AbbVie is issuing an urgent field correction notification due to an increased number of reports of disconnections of the AbbVie 20FR PEG tube from the Y-connectors. |
| Product | AbbVie PEG Kit 20 FR |
| Quantity | 541 units |
| Distribution | U.S. consignees located throughout the country and Puerto Rico. Foreign Consignees: Worldwide. |
| Initiated | 2016-11-22 |
| Classified | 2016-12-17 |
| Terminated | 2019-07-09 |
| Recall number | Z-0786-2017 |
| Initiation | Voluntary: Firm initiated |
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Class II recall — AbbVie Inc. (Z-0786-2017).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/75794/
Alerts for AbbVie Inc.
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.